Raghunandan Vikram MBBS, FRCR, Presenter: Nothing to Disclose

Aparna Balachandran MD, Abstract Co-Author: Nothing to Disclose

Christopher G. Wood MD, Abstract Co-Author: Consultant, Pfizer Inc Investigator, Pfizer Inc Speaker, Pfizer Inc Consultant, Argos Therapeutics, Inc Investigator, Argos Therapeutics, Inc Investigator, GlaxoSmithKline plc

Pheroze Tamboli MD, Abstract Co-Author: Nothing to Disclose

Naveen Garg MD, Abstract Co-Author: Consultant, Document Storage Systems, Inc

Venkata S. Katabathina MD, Abstract Co-Author: Nothing to Disclose

Srinivasa R. Prasad MD, Abstract Co-Author: Nothing to Disclose

To provide a current update on cytogenetics & molecular biology of cystic nephromas and mixed epithelial and stromal tumors of the kidney To describe the MDCT/MRI findings of these two entities.

Epidemiology, etiopathogenesis, cytogenetics, immunohistochemistry, natural history and clinical manifestations of cystic nephromas and mixed epithelial and stromal tumors of the kidney. Comparative appearances of Cystic nephromas and MESTs on pathology and on cross sectional imaging studies (shape, size, relationship to renal sinus, enhancement, septal thickness, solid components)

Adult cystic nephromas and mixed epithelial and stromal tumors are benign cystic neoplasms of the kidney and are considered separate entities in the 2004 World health organization classification of renal neoplasms. However, there is considerable overlap in epidemiological/clinical features, natural history and imaging characteristics of these two entities. Recent studies in immunohistochemistry also suggest that these two are related and may represent two ends of the same spectrum.

Vikram, R, Balachandran, A, Wood, C, Tamboli, P, Garg, N, Katabathina, V, Prasad, S, Cystic Nephroma and Mixed Epithelial and Stromal Tumor of the Kidney: A Single Clinical Entity?.  Radiological Society of North America 2013 Scientific Assembly and Annual Meeting, December 1 - December 6, 2013 ,Chicago IL. http://archive.rsna.org/2013/13021095.html